NASDAQ, GPRO - Gopro Inc Cl A

We are a global leader in the development, manufacture and marketing of rapid,  accurate and cost-effective nucleic acid probe-based products used for the  clinical diagnosis of human diseases and for screening donated human blood. We  also develop and manufacture nucleic acid probe-based products for the detection  of harmful organisms in the environment and in industrial processes. We market  and sell our clinical diagnostic products in the  1  --------------------------------------------------------------------------------  Table of Contents   United States directly and outside the United States primarily through  distributors, as well as through our direct sales force, and we also market and  sell our other products through collaborative partners.  Founded in 1983, we pioneered the scientific and commercial development of  nucleic acid testing, or NAT.  ...

Sector:	Health Care
Industry:	Medical/Dental Instruments
P/E Ratio:	4.1378
PEG Ratio:	N/A
EPS:	N/A
DivYield:	N/A
PtB:	1.067
PtS:	1.03
EBITDA:	N/A
Shares:	131.29M
Market Cap:	185.12M
52wk range:	0.40 - 2.37

216.73.216.229
United States